Pulmoner Langerhans Hücreli Histiyositozis (4 Olgu Nedeniyle)
Abstract
Keywords
References
- 1. Pietra GG, Salhany KE. Lymphoproliferative and hematologic diseases involving the lung. In: Fishman AP, ed. Pulmonary diseases and disorders. 3rd ed. New York: Me Graw Hill; 1998. p.1875-6.
- 2. King TE, Crausman RS. Pulmonary histiositozis X. In:Fishman AP, ed. Pulmonary diseases and disorders. 3rd ed. New York: Me Graw Hill; 1998;76:1163-70.
- 3. Youkles LH, Grizzanti JN, Liao, et al. Decreased tobacco-glycoprotein induced lymphocytes in vitro in pulmonary eosinophilic granuloma. Am J Res Crit Care Med 1995;151: 145-50.
- 4. Sakata N, Toguchi N, Kimura M, et al. Development of Langerhans cell histiocytosis associated with chronic active Epstein-Barr virus infection. Pediatr Blood Cancer 2007 May; (Epub ahead of print).
- 5. Dacic S, Trusky C, Bakker A, et al. Genotypic analysis of pulmonary Langerhans cell histiocytosis. Hum Pathol 2003;34:1345-9.
- 6. Amir G, Weintraub M. Association of cell cycle-related gene products and NF-kappaB with clinical parameters in Langerhans cell histiocytosis. Pediatr Blood Cancer 2008;50:304-7.
- 7. Marchal J, Kambouchner M, Tazi A, et al. Expression of apoptosis-regulatory proteins in lesions of pulmonary Langerhans cell histiocytosis. Histopathology 2004;45:20-8.
- 8. Çetinkaya E, Turna A, Gençoğlu A ve ark. Pulmoner histi-yositozis X. Toraks Dergisi 2003;4:186-90.
Details
Primary Language
Turkish
Subjects
Thoracic Surgery, Chest Diseases
Journal Section
Case Report
Authors
Nilgün Kalaç
*
This is me
Türkiye
Publication Date
November 20, 2007
Submission Date
November 11, 2007
Acceptance Date
November 11, 2007
Published in Issue
Year 2007 Volume: 1 Number: 3